Peerless Biotech Pvt. Ltd.

Rapid Test Company’ offering Rapid Diagnostic Tests (RDTs).
The five key diagnostic segments we focus on are: Cardiac Markers (Troponin I, CKMB, Myoglobin, CRP); Viruses (HIV-1/2, HBV, HCV); Microbiology (Malaria Pv/Pf, Syphilis, H. Pylori, Dengue, Chlamydia, Strep A); Tumor Markers (AFP, PSA, FOB, Ferritin); Hormones (hCG, LH, FSH, Prolactin and TSH). We also offer RDTs for Drugs of Abuse.

Activity:

- Manufacturing
- Sales & Distribution

Product / Technology type(s) covered:

- Devices
- Diagnostics
- OTC (over the counter drugs)
- Reagents

Therapeutic targets:

- AIDS
- Cancer
- Diabetes
- Gastrointestinal
- Infectious Diseases
- Pediatrics
- Stroke
- Women's Health

Markets Covered

a. HeadQuarter: India

b. Continent(s) active: Asia

c. Countries active: India, Srilanka, Nepal, China, Thailand

Corporate data:

Number of Employees: 51

Turnover:

Amount:	Year:	Currency:
568320	2002	US Dollar

Year founded: 2001

Partners / Alliances: Standard Diagnostics, Inc-Korea; Veda Lab-France; Acon Biotech-China